12-month prospective clinical phase IV trial to investigate the local and systemic tolerability of Clonid-Ophtal® 1/8% eye drops versus Tim-Ophtal® 0.5% eye drops in patients with ocular hypertension or open-angle glaucoma

Machine translation Machine translation
Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
INTERVENTION: Trade Name: Clonid‐Ophtal 1/8% Product Name: Clonid‐Ophtal 1/8% Product Code: 815 Pharmaceutical Form: Eye drops, solution INN or Proposed INN: Clonidinhydrochlorid Concentration unit: % percent Concentration type: equal Concentration number: 1/8‐ Trade Name: Tim‐Ophtal 0,5% Product Name: Tim‐Ophtal 0,5% Product Code: 116 Pharmaceutical Form: Eye drops, solution INN or Proposed INN: Timololhydrogenmaleat Concentration unit: % percent Concentration type: equal Concentration number: 0,5‐ Pharmaceutical form of the placebo: Eye drops, solution Route of administration of the placebo: Ocular use
Epistemonikos ID: 83348e739628f8e38210e5bfe399c95995b0b02e
First added on: Aug 21, 2024
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: Deutsch

If you prefer to see the machine translation we assume you accept our terms of use